Tower Research Capital LLC (TRC) - CORVUS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$36,116
-23.2%
24,737
+20.4%
0.00%
-50.0%
Q2 2023$47,043
+427563.6%
20,543
+63.1%
0.00%
Q1 2023$110.0%12,597
-1.0%
0.00%
Q4 2022$11
-99.9%
12,718
+9.0%
0.00%
Q3 2022$10,000
+11.1%
11,668
+25.0%
0.00%
Q2 2022$9,000
+80.0%
9,333
+214.0%
0.00%
Q1 2022$5,000
-88.1%
2,972
-83.1%
0.00%
-100.0%
Q4 2021$42,000
-58.8%
17,564
-17.1%
0.00%
-66.7%
Q3 2021$102,000
+410.0%
21,199
+177.0%
0.00%
+200.0%
Q2 2021$20,000
-84.8%
7,654
-82.1%
0.00%
-50.0%
Q1 2021$132,000
+4300.0%
42,786
+4675.2%
0.00%
Q4 2020$3,000
-88.5%
896
-86.1%
0.00%
Q3 2020$26,000
+420.0%
6,450
+247.9%
0.00%
Q2 2020$5,0001,854
+827.0%
0.00%
Q1 2020$0
-100.0%
200
-90.7%
0.00%
Q3 2019$6,000
+200.0%
2,147
+426.2%
0.00%
Q1 2019$2,000
-95.0%
408
-96.2%
0.00%
-100.0%
Q4 2018$40,000
+185.7%
10,810
+547.3%
0.00%
+200.0%
Q3 2018$14,000
-17.6%
1,670
+8.9%
0.00%0.0%
Q2 2018$17,000
-59.5%
1,533
-57.8%
0.00%
-75.0%
Q1 2018$42,000
+162.5%
3,633
+139.2%
0.00%
+100.0%
Q4 2017$16,000
-56.8%
1,519
-33.0%
0.00%
-33.3%
Q3 2017$37,000
-53.8%
2,267
-65.5%
0.00%
-66.7%
Q2 2017$80,000
+281.0%
6,571
+360.5%
0.01%
+350.0%
Q4 2016$21,000
-57.1%
1,427
-58.7%
0.00%
-60.0%
Q2 2016$49,000
+11.4%
3,455
+13.5%
0.01%
-28.6%
Q1 2016$44,0003,0440.01%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 3,749,379$18,147,0003.77%
VR Adviser, LLC 3,427,461$16,589,0002.13%
ADAMS STREET PARTNERS LLC 3,275,616$15,854,0002.04%
Telemetry Investments, L.L.C. 196,168$949,0001.28%
DC Investments Management, LLC 50,709$245,0000.46%
Orbimed Advisors 6,943,654$33,607,0000.37%
EcoR1 Capital, LLC 2,081,077$10,072,0000.35%
BVF INC/IL 1,370,947$6,635,0000.26%
Ikarian Capital, LLC 757,545$3,666,0000.26%
CHI Advisors LLC 165,927$803,0000.23%
View complete list of CORVUS PHARMACEUTICALS INC shareholders